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The negative aspects of genetically
modified (GM) foods are often presented
in the media. Reports of ‘supercrops’,
‘superweeds’, allergic reactions, health
hazards and environmental damage have
appeared. So, are GM foods really bad
news or is the public simply being misled
about the good and bad aspects of this
technology?
Since man started to modify plants some
10,000 years ago, farmers have been
searching for new crops and varieties that are
more productive. With the discovery of
fundamental genetics, organisms have been
selected to express a range of required traits.
Hence, new animal strains, plant varieties
and hybrids have been produced. Now, with
the introduction of recombinant DNA
techniques, the transfer of DNA between
species is possible. 
First-generation GM foods were designed
to provide growers with alternative crop
management solutions. Here, selected genes
were identified from plants and other sources
and then transferred to the crop plant.
Subsequent modifications provided traits
such as enhanced nutrition or health
promoting characteristics; however, GM food
remains a controversial subject because of
public misconception of the risks. 
With changing climatic conditions and pest
infestations, growing food crops is becoming
a real challenge to farmers both locally and
internationally, a situation compounded by
the increase in population. With a predicted
global increase of 10 billion by the middle of
the century, it is imperative that food crops
are found that are more productive and are
resistant to the changing weather conditions
and to more pests.
Against this background, many
biotechnology companies are making use of
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Genetically 
modified food
Good news but bad press
As a concept, the genetic manipulation of plants and animal is far from new, 
but it is only since the introduction of recombinant technology that concerns 
have been expressed. In this overview, Pamela Greenwell and Sanjiv Rughooputh 
look at the wide-ranging effects of DNA transfer between species. 
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‘Genetically modified food remains 
a controversy subject because of 
public misconception of the risks’
recombinant gene technology to produce 
GM crops that would, in theory, be able to
meet these conditions. For example, different
genes have been studied that would make
plants more resistant to pests or allow them
to grow in adverse weather conditions.
Natural insecticides 
and edible vaccines
One gene currently under investigation is
from Bacillus thuringiensis. The so-called 
Bt gene produces proteins such as Cry1Ab
and Cry9c, which are toxic to certain insects.
The rationale for the introduction of this
gene into crops under culture is that it will
produce plants that are resistant to certain
insects, thus reducing or eliminating the
need to use pesticides. The quality of food
thus produced will be both better and
cheaper. 
The Bt gene is currently used in corn 
(eg Starlink corn developed by Aventis
CropScience) and soybeans. Trials in rice are
underway in China, while scientists in Kenya
have been trying to develop a ‘golden maize’.
However, there are fears that farmers
growing crops containing the Bt gene will use
other insecticides more liberally as the plants
will be resistant to certain insects. Also,
transfer of the Bt gene from the food crop to
other plants could result in the production of
a ‘superweed’ that might prove difficult to
eliminate. 
Interest has also been shown in the gene
that allows sorghum to grow in extremely 
dry conditions. Researchers in Texas have
been studying this plant for the past 15 years
and they are now confident that genetic
manipulation will allow it to grow in arid
conditions.
Other concepts that have surfaced recently
include the delivery of ‘edible vaccines’,
made possible when a gene with vaccine
potential (eg a viral surface antigen) is
introduced into tomato or potato plants. 
The aim is to deliver low-cost vaccines to
remote, inaccessible places in, for example,
rural Africa.
Is GM food safe?
Thus far, GM food has not been proven to be
harmful, although there have been some
fears that it may produce allergies, which are
immunological responses to the presence of
foreign proteins in the body. Recently, Sten 
et al.1 investigated patients who were
‘soybean sensitised’ to determine the
allergenicity of different soybeans. Both GM
and non-GM soybean were tested by
measuring the levels of IgE and histamine
release; however, they were unable to
establish any allergenic potency in the GM
soybean. 
Similarly, Raybourne and colleagues2
investigated the insecticidal protein Cry9c,
which is suspected of causing allergic
reaction. On testing the sera of 18 people
they concluded that there was no link
 
between allergic conditions and Cry9c.
However, although the protein could not be
incriminated, they suggested that
glycosylated epitopes of Cry9c expressed 
in the plant could be responsible for the
allergy. To date, this problem has not been
investigated on a large scale.
The International Food Biotechnology
Council (IFBC)3 published on the issue of 
GM food in 1990 and subsequently specific
guidelines have been produced by the Food
and Agriculture Organisation (FAO), the
International Life Sciences Institute (ILSI)
and the Organisation for Economic
Cooperation and Development (OECD). 
The EU has also produced legislative policies
related to transgenic products (EU Directive
2001/18/Ce).
Other causes for concern include the
safety of any new proteins synthesised, and
their potential side effects, not only on the
individual but also on the bacteria that may
be exposed to the new protein, either in the
intestinal tract or in the soil. Although a
single gene may not have an adverse effect,
the interaction with other genes may affect
the enzymatic and metabolic pathways and
thus have an impact on the phenotype of
recipient cells.
From the time of Mendel, plant biologists
have crossbred species to produce more
resistant and productive traits. This type 
of crossbreeding transfers uncontrolled and
randomly assorted groups of genes. In
contrast, recombinant DNA technology
allows precise identification, characterisation,
enhancement and transfer of selected genes. 
There are well-founded fears about
conferring resistance during the process 
of selection of hybrid plants. Indeed,
antibiotics such as kanamycin, ampicillin 
or chloramphenicol are used as selectable
markers to identify organisms that have taken
up the gene of interest. However, new
concepts have been developed that do not
require the use of antibiotics as a selectable
marker for gene uptake.
Alternative methods of selection
The simple sugar mannose can be used for
selection. Plants convert mannose to
mannose-6-phosphate, using a hexokinase.
Susceptible plants that cannot metabolise
mannose-6-phosphate accumulate it and this
inhibits growth. Thus, the plants are
transformed with the gene of interest,
together with the gene for phosphomannose
isomerase (PMI). The latter converts
mannose-6-phosphate to fructose-6-
phosphate, which is easily metabolised. 
The plants are then grown on mannose. 
Only those that have taken up the gene 
of interest and PMI will grow, while those
that have not been transformed will not. 
The plants are then screened for the uptake
of the gene of interest.
Health and recombinant drugs
Recombinant DNA technology has been used
for decades in the health sector. Scientists at
Genentech first cloned human insulin in
1978 and recombinant insulin was marketed
in 1982. Furthermore, recombinant hepatitis
B vaccine is offered to all health service
workers to prevent HBV infection. The US
Food and Drug Administration (FDA) tested
these products stringently before they were
made available for use.
Antibiotic resistance
The public remains sceptical about GM
products. But what is the underlying fear? 
Is it antibiotic resistance in the food chain? 
The veterinary industry is a heavy user 
(or abuser) of antibiotics as these are given 
to animals prophylactically to enhance
growth. The animals are then slaughtered 
for human consumption and the antibiotics
find their way into humans through the food
chain. As there is considerable pressure on
farmers to produce ever larger quantities of
cheap meat, it is unlikely that the practice 
of using prophylactic antibiotics in animal
husbandry will cease.
As Malarkey4 pointed out, GM foods
undergo considerably greater scrutiny of 
their nutritional and toxicological content
than do traditional crops, and this makes
them safer. Some 1700 GM foods have been
analysed in the EU and around 7800 in the
USA. In the EU only five GM crops have 
been approved, and the amount of GM food
produced accounts for just 0.03% of world
production. In the USA, 50 GM crops have
been approved.
Global perspective
Objective assessment might suggest that 
GM food is safe; however, people should be
comfortable with what they eat, and it is
imperative that the public be made aware 
of which products are genetically modified 
so that an informed choice can be made.
Clearly, as the farming industry is under
pressure to produce more food at a
competitive price, it is almost inevitable 
that GM foods will find their way into
markets and supermarkets. 
However, the value of GM crops to the
Third World should not be underestimated.
Famine and poverty are responsible for
millions of deaths each year, and thus crops
designed to be resistant to pests, grow in
unfavourable conditions and produce
products with a higher calorific value could
save lives. 
Importantly, liaison with biotechnology
companies is essential to ensure that crops
which undergo genetic modification are fully
tested and that their effects are well
scrutinised to prevent the uncontrolled
spread of the introduced genes. n
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‘Genetically modified
foods undergo
considerably greater
scrutiny of their
nutritional and
toxicological
content than do
traditional crops’
Under scrutiny
Fear that GM plants may produce harmful
proteins remains a concern. Genetic
modification is carried in a controlled
manner. Production of any unusual protein
can be detected and accounted for using
techniques such as the polymerase chain
reaction (PCR). 
